Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation
SCIE
SCOPUS
Cited 65 time in
WEB OF SCIENCE
Cited 51 time in
Scopus
-
Title
- Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation
-
Author(s)
- Shim, JS; Kim, DH; Jung, HJ; Kim, JH; Lim, D; Lee, SK; Kim, KW; Ahn, JW; Yoo, JS; Rho, JR; Shin, J; Kwon, HJ
-
Alternative Author(s)
- 노정래
-
Publication Year
- 2002-09
-
Abstract
- Curcumin and some of its derivatives were known as in vivo inhibitors of angiogenesis. In present study. a novel curcumin derivative, named hydrazinocurcumin (HC) was synthesized and examined for its biological activities. HC potently inhibited the proliferation of bovine aortic endothelial cells (BAECs) at a nanomolar concentration (IC50 = 520 nM) without cytotoxicity. In vivo and in Nitro angiogenesis experiments showed HC Lis a new candidate for anti-angiogenic agent. (C) 2002 Published by Elsevier Science Ltd.
-
ISSN
- 0968-0896
-
URI
- https://sciwatch.kiost.ac.kr/handle/2020.kiost/5670
-
DOI
- 10.1016/S0968-0896(02)00129-3
-
Bibliographic Citation
- BIOORGANIC & MEDICINAL CHEMISTRY, v.10, no.9, pp.2987 - 2992, 2002
-
Publisher
- PERGAMON-ELSEVIER SCIENCE LTD
-
Subject
- COLON CARCINOGENESIS; DIETARY CURCUMIN; TUMOR PROMOTION; ANGIOGENESIS; ANALOGS; TETRAHYDROCURCUMIN; MECHANISMS; GROWTH
-
Type
- Article
-
Language
- English
-
Document Type
- Article
- Files in This Item:
-
There are no files associated with this item.
Items in ScienceWatch@KIOST are protected by copyright, with all rights reserved, unless otherwise indicated.